We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Orexigen Therapeutics, a biotech that was one of a wave of companies bringing through weight-loss pills, has announced that it has filed for bankruptcy.
Orexigen Therapeutics, Inc. announced that Health Canada has completed its screening phase and accepted for review a New Drug Submission for marketing approval of Contrave®.